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There is an emerging body of work indicating that genes, epigenetics, and the in utero environment can impact whether or not
a child is obese. While certain genes have been identiﬁed that increase one’s risk for becoming obese, other factors such as excess
gestational weight gain, gestational diabetes mellitus, and smoking can also inﬂuence this risk. Understanding these inﬂuences can
help to inform which behaviors and exposures should be targeted if we are to decrease the prevalence of obesity. By helping parents
and young children change certain behaviors and exposures during critical time periods, we may be able to alter or modify one’s
genetic predisposition. However, further research is needed to determine which eﬀorts are eﬀective at decreasing the incidence of
obesity and to develop new methods of prevention. In this paper, we will discuss how genes, epigenetics, and in utero inﬂuences
aﬀect the development of obesity. We will then discuss current eﬀorts to alter these inﬂuences and suggest future directions for this
work.
1.Introduction
Childhood obesity is a worldwide public health concern
with several etiologic inﬂuences. The intergenerational
relationship between parent and child obesity has been
welldescribed [1], and twin studies have estimated that genes
are responsible for 40–75% of the phenotypic variance of
obesity [2–4]. However, evolutionary changes in the genome
cannotexplainthetremendousincreaseinobesityprevalence
over the past 30 years. Most likely, the genetic susceptibility
to obesity has always existed, but is now becoming more
evident due to the inﬂuence of the obesogenic environment.
This gene-environment interaction likely drives the obesity
epidemicandhelpstoexplainindividualvariationsinobesity
development, that is, why one sedentary child eating a high-
fat diet becomes obese and another child who eats similarly
does not. In addition to this interaction, animal studies
have suggested that epigenetic inﬂuences, like nutritional
exposure in utero,canalterone’s geneexpression and further
impact the risk for obesity. Understanding how certain fac-
tors can modify gene expression during fetal development
and early childhood can help to explain the rapid rise of
obesity during a time when minimal to no populationwide
genomic changes have occurred. This knowledge may ulti-
mately help us prevent the development of obesity in a
signiﬁcant number of children. In this paper, our goal is to
outline the inﬂuence of genetic, epigenetic, and in utero
factors on the development of childhood obesity. With this
information, we can lay the groundwork for future obesity
prevention eﬀorts.
2.Genetics
Over the past several years, many discoveries have been made
regarding the genetic variation that inﬂuences complex dis-
eases like cardiovascular disease and obesity [5]. These new
discoveries have largely resulted from genomewide associa-
tion studies where the application of high-throughput geno-
typing of millions of genetic markers enables researchers to
examine genetic associations on a genomewide basis. Recent
reports indicate that at least 32 genes contribute to common
forms of obesity [6–11]. A number of these have also been
conﬁrmedascontributorstopediatricobesity[10,12].Many2 International Journal of Pediatrics
of these genes are thought to be related to the development
of obesity through the dysregulation of leptin or other
metabolic hormones in the body. However, a majority of the
newly discovered genes are expressed in the brain, emphasiz-
ing the role of the central nervous system in obesity risk [8].
The obesity-associated variant in the FTO gene has
garnered particular interest in pediatrics because of its
association with increased weight and ponderal index at
2w e e k so fa g e[ 13]. FTO is located on the long arm of
chromosome 16 and is expressed in the brain, speciﬁcally the
hypothalamic nuclei. Those who are homozygous for the at-
riskallelehavebeenfoundtobeupto3kgheavierthanthose
who do not have the allele [10]. This weight gain is likely due
to the gene’s involvement in the regulation of energy intake.
According to recent studies, individuals carrying the at-risk
allele prefer energy dense food [14], have reduced feelings of
satiety [15], display loss of control over eating [16], consume
more fat and calories (even after adjusting for BMI) [17],
and display a greater tendency towards consuming palatable
foodsaftereatingameal[18].Thus,FTOseemstopredispose
individuals to greater caloric intake and reduced feelings of
satiety. On the other hand, FTO does not seem to be related
to energy expenditure. A meta-analysis of 45 studies found
that adults who were physically active could attenuate the
odds of obesity associated with FTO by almost 30% [19].
Thus carrying a gene for obesity does not necessarily pre-
destine one to become obese [20] but, rather, increases one’s
riskinthefaceofanobesogenicenvironment.Unfortunately,
this attenuation of obesity risk via physical activity was not
seen in children [19]. Nevertheless, taken together, these
results suggest that interventions targeting food availability
or physical activity may mitigate the increased genetic risk
found in those with the FTO gene.
In addition to common forms of obesity, several rare,
monogenic forms of obesity have been described including
Prader-Willi syndrome and Bardet-Biedl syndrome. One
of the most common forms of monogenic obesity, repre-
senting up to 5% of severe childhood obesity, is linked to
melanocortin-4 receptor (MC4R) gene mutations [21, 22].
The MC4R gene is located on the long arm of chromosome
18 and encodes a G-protein-linked receptor [23] that is
primarily expressed in the brain, more speciﬁcally in the
paraventricular nucleus of the hypothalamus. The receptor
is typically stimulated by insulin and leptin release which
signals proopiomelanocortin (POMC) neurons to synthesize
and release alpha-melanocyte stimulating hormone (α-
MSH). When α-MSH binds to MC4R, individuals begin
to feel satiated and increase energy expenditure through
thermogenesis. Mutations in the MC4R gene can decrease
this response and lead to rare familial forms of severe obesity
[21, 24]. Mutations lead to excess intake of energy, and indi-
viduals with this mutation have displayed a preference for
foods high in total and saturated fats [25]. Unlike FTO how-
ever, it is also associated with decreased energy expenditure
[26]. Thus mutations in MC4R seem to impact both sides
of the energy equation, that is, by increasing consumption
anddecreasingexpenditure.Whilethegenehasanautosomal
dominant mode of transmission, it also has incomplete
penetrance, thereby making clinical diagnosis diﬃcult. Its
incomplete penetrance however suggests that other factors,
possiblyepigeneticorenvironmental,maybeimpactingphe-
notypic expression. Given the diﬀerent mechanism of action
associated with this gene, it is important not to lose sight of
the rare but often severe forms of monogenic obesity as we
consider which environmental manipulations to pursue.
3.Epigenetics
While several genes have been linked to excess weight gain,
the existence of these genes cannot explain the rapidly
growing prevalence of obesity. Epigenetics is the study of
how early environmental inﬂuences aﬀect gene expression
and ultimately growth, development, and risk for disease
without changing the underlying DNA sequence. Epigenetic
mechanisms involve chemical processes such as DNA methy-
lation, covalent modiﬁcations to histones that bind to DNA,
and chromatin folding that can change gene expression
and chromatin structure without changing the nucleotide
sequence. Epigenetic changes can sometimes promote the
expression of a gene that has typically been silent or silence a
gene that is usually active. Examples of this phenomenon are
widely evident as stem cells diﬀerentiate into speciﬁc somatic
cells, like heart tissue or brain tissue, and genes are hypo- or
hypermethylated to become cancerous.
Inﬂuences that may alter gene expression include inﬂam-
mation, aging, oxidative stress, and hypoxia [27]. Scientists
are also examining whether other environmental factors like
maternal obesity and nutritional quality before or during
pregnancy can cause epigenetic changes in the fetal genome
and subsequently increase the risk of a child becoming
overweight. Nutritional components that may inﬂuence the
methylation of epigenetically susceptible loci include folic
acid, vitamin B6 and 12, selenium, choline and betaine,
methionine, soy genistein, bisphenol A, tocopherols, diallyl
disulﬁde in garlic, and tea polyphenols [28].
4. AnimalStudies
For many years, scientists have been using animal models to
manipulate the genome and demonstrate how environmen-
tal exposures can alter the expression of genes so that certain
characteristics, such as risk for obesity, can be suppressed or
expressed. The agouti mouse, which was genetically altered
tohaveyellowfur,hasbeenusedinmanyofthesestudies.For
example, scientists have demonstrated that supplementing
the mouse diet with methyl donors (like dietary folates, vita-
minB12,methionine,andcholine)canaltertheexpressionof
their genome and revert their coat color back to black [29].
While these epigenetic changes may or may not be passed
down to the next generation, it does appear that it can be re-
establishedinsubsequentgenerationswithcontinueddietary
supplementation [30].
Interestingly, the yellow agouti mouse is also heavier and
has a higher risk for hyperinsulinemia, diabetes, and tumors.
The tendency for oﬀspring of the yellow agouti mouse to be
overweight is exacerbated if dams (mothers) are overweight.
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has previously been shown to revert the oﬀspring’s coat
color back to black, also prevented the future transmission
of obesity to the oﬀspring [31]. Thus changes in diet may
be epigentically altering their genome so that these mice are
phenotypically black and lean again. In addition to folate
and vitamin B12, genistein, the major phytoestrogen in soy,
has been shown to reduce the risk of obesity in the agouti
mouse [32]. Whether or not genistein has similar eﬀects on
fat mass in humans is unknown. However, it is postulated
that its methylating activity may explain the diﬀerence in
cancer rates between Asians and Westerners. While studies
that supplement human diets with methyl donors would be
diﬃcult to conduct, these animal studies suggest that the
diet of pregnant mothers may be altering gene expression
via epigenetic mechanisms and would therefore play an
important role in inﬂuencing the health of future oﬀspring.
The energy density of the food consumed during gesta-
tion may also be an important factor in determining one’s
phenotypic expression. Oﬀspring of rats that are genetically
susceptible to diet-induced obesity (DIO) are known to be
heavier than oﬀspring of rats who are diet resistant (DR).
DIOdamswhoconsumeahigh-energydietorchow(normal
energy diet) during gestation generally have oﬀspring who
are heavier than those from DR mothers exposed to either
diet [33]. However, the exposure to high calorie diets during
the gestational period exacerbated the risk of obesity in the
DIO oﬀspring such that those who were exposed to high-
energy diets had the highest birth weight (compared to DIO
oﬀspring of dams on chow diets and DR oﬀspring of dams
on high calorie or chow diets) and demonstrated the greatest
weight gain during the subsequent weeks despite being on
similar diets as the DR oﬀspring.
Another rat study, controlling for genetic inﬂuence,
amount of gestational weight gainin the dams, and any post-
natal eﬀects from the mother via lactation, also found that
the energy density of the dam’s diet aﬀected the oﬀspring’s
weight trajectory, particularly if the oﬀspring was exposed to
ahigh-energydiet[34].Whenexaminingthegeneexpression
of adipose tissue and hypothalamus, it appeared that expo-
sure to high-energy diets in utero caused an upregulation of
c ertaingenepr oductsintheoﬀspringwhichresultedinmore
eﬃcient storage of the excess energy they consumed post-
natally [35]. Other studies similarly suggest that maternal
food intake that leads to excess gestational weight gain and
associated metabolic changes in the in utero environment
are aﬀecting hypothalamic expression of genes involved in
energy regulation [36, 37]. These studies demonstrate that
an obesogenic in utero environment not only aﬀects weight
status at birth, but can increase the risk for obesity by
priming the oﬀspring’s body to respond in a certain way to
subsequent environmental or nutritional exposures. These
results suggest that eﬀorts to reduce one’s exposure to high
caloriediets,inuteroandafterthechildisborn,maybequite
important to reduce one’s risk for obesity.
Animal studies have also examined the inﬂuence of envi-
ronmental exposures like nicotine and alcohol on oﬀspring
development. Findings suggest that nicotine exposure in
utero increases postnatal weight gain [38]a n dm a ya ﬀect
the development of hypothalamic function and subsequent
appetite control through the upregulation of certain gene
products [39, 40]. When exposed to alcohol in utero, rats
appear to have increased gluconeogenesis and insulin resis-
tance, making them more at risk for Type 2 diabetes
[41–43]. These studies highlight the importance of other
environmentalexposuresinexplainingtheriseinobesityand
its associated comorbidities.
It is important to note that epigenetic changes can also
occur postnatally. Since some tissues/organs and regulatory
mechanisms are not fully developed at birth, there is still
time to alter the expression of these genes once the oﬀspring
are born. In animal studies, cross-fostering, or suckling oﬀ-
spring with nonbiological mothers, changes the nutritional
exposure of the oﬀspring and can impact the development
of obesity. For example, when DR oﬀspring (who have no
genetic risk for obesity) were fostered by obese DIO dams,
they gained more weight than their counterparts who were
fostered by DR dams. They also developed higher levels of
insulin and leptin and had higher oral glucose tolerance test
results[44].Conversely,whenDIOoﬀspringwerefosteredby
DR dams, they gained less weight compared to those suckled
by DIO dams. They also had lower basal glucose levels [44].
Cross-fostering not only aﬀected the oﬀspring’s weight and
hormonelevels,butchangedmRNAexpressionofneuropep-
tides, insulin, and leptin receptors in the hypothalamus. The
authors postulate that elements in the breast milk (such as
higher insulin levels and lower polyunsaturated and mono-
unsaturated fatty acid content in the milk of obese DIO
dams) may have played a role in inﬂuencing these outcomes.
Additional studies have examined the impact of consum-
ing high carbohydrate (HC) milk formula on the develop-
ment of rats [45]. In these studies, the nutritional quality
of milk was altered from its usual fat-rich state to a high-
carbohydrate state without altering the total calorie content.
After exposure to this milk in the immediate postnatal
period, these pups developed chronic hyperinsulinemia and
adult-onset obesity. At a molecular level, these pups had
greater expression of mRNA related to pancreatic islet cell
function and peptides of the brain (Neuropeptide Y, Agouti-
related peptide, POMC, and MC4R). They were also able to
transferthesetraits(orriskproﬁle)totheiroﬀspringwithout
any further manipulations to the oﬀspring’s diet. These
studies demonstrate the power of postnatal factors in mod-
ifying one’s genetic predisposition and may further explain
how environmental exposures are aﬀecting the increasing
prevalence of obesity.
5.HumanStudies
Replicating these studies in humans is particularly challeng-
ing because of the great variety of epigenetic mechanisms
that can inﬂuence gene expression as well as a lack of under-
standing as to where in the human genome and when during
development these changes need to occur. Furthermore,
studiesinhumansarecomplicatedbythemyriadofinterper-
sonal and environmental factors that inﬂuence growth and
development throughout life. Finally, there are many ethical
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trials that manipulate exposures in utero and alter epigenetic
expression. Conducting tests to conﬁrm that epigenetic
changes were made can also be diﬃcult in humans, thereby
limiting our ability to deﬁne clear relationships between
exposures and outcomes. Given these limitations, animal
studies will often be needed to infer underlying mechanisms.
However, there are some human studies that suggest
epigenetic changesareoccurring. One suchline ofresearchis
with bariatric surgery patients. In an earlier study, Marceau
et al. [46] compared the results of pregnancies in a group of
women (mean BMI = 47.1 ± 8.3) before they had biliopan-
creatic diversion surgery (a form of bariatric surgery) and in
another group of women after t h e yh a ds u r g e r y( m e a nB M I
= 30.9 ± 6.4). Of the 166 infants born in the postsurgery
group, only 7.7% had fetal macrosomia (excessive weight at
birth) compared to 34.8% of the infants born to mothers in
the presurgery group (n = 1245 infants). In further analyses,
a set of mothers who had been pregnant before and after
weight loss surgery were found to have gained 50% less
weight during their postsurgery pregnancy. The frequency of
macrosomia was 88% lower in the postsurgery oﬀspring and
theproportionofchildrenwhowereseverelyobesedecreased
by 70% [47]. These children were also noted to have lower
blood glucose, insulin, and triglyceride levels. After surgery,
mothers had signiﬁcant reductions in BMI, blood glucose,
insulin,lipid,andadipokinelevels.Thesematernalmetabolic
changes likely reﬂect changes in the in utero environment
for the fetus, suggesting that the diﬀerences in the metabolic
environment aftersurgery inﬂuenced child weight outcomes.
While the authors could not control for other environmental
exposures and the inﬂuence of genetics, studies in animals
where the mother’s metabolic proﬁle has been altered while
controlling for genetic and environmental inﬂuences found
similar changes in the oﬀspring’s weight as seen in this
human study [34].
Several studies have also shown that excessive gestational
weight gain and its associated alterations in the intrauterine
environment can contribute not only to overly rapid fetal
and infant growth but to the future risk of childhood
overweight [48, 49]. In the Growing Up Today Study cohort,
Oken and colleagues [50] were able to conﬁrm that greater
weight gain during pregnancy, controlling for maternal
prepregnancy BMI, was associated with increased risk of
obesity in adolescents (OR = 1.42, 95% CI 1.19–1.70). There
were also greater odds of having a large-for-gestational-age
(LGA) infant if the mothers gained 45lbs or more compared
to those mothers who gained 20–24lbs (OR = 4.14, 95% CI
3.33–5.15). This study was unable to tease apart the eﬀect
of shared maternal-child dietary environments and shared
genetics. However, controlling for maternal BMI helped to
demonstrate that excessive weight gain itself can also aﬀect
child weight status. Other studies have shown that excess
weight gain and hyperglycemia in mothers can result in fetal
hyperinsulinemia, which has been associated with high birth
weight and impaired glucose tolerance in adolescence [51].
In addition to weight gain, recent research has found
that maternal dietary intake (speciﬁcally low carbohydrate
intake) during early pregnancy was associated with gene
methylation linked with higher oﬀspring weight [52]. Other
studies have also found independent associations between
maternal dietary intake during pregnancy and oﬀspring
weight [53], adolescent blood pressure [54], and dietary
patterns [55]. These data, in conjunction with animal data
showing changes in hypothalamic gene expression when rats
are exposed to certain foods in utero [36, 37], suggest that
epigenetic changes may be partially mediating the eﬀects of
excess gestational weight gain and increased obesity risk in
children.
In addition to gestational weight gain, gestational dia-
b e t e s( G D M ) ,w h i c hi sm a r k e db yn e wo n s e th y p e r g l y c e m i a
and insulinemia during pregnancy, has been considered
another phenomenon that has the potential to alter the in
utero environment and subsequent phenotypic expression
of genes. In a cohort of large-for-gestational-age (LGA) and
appropriate-for-gestational-age (AGA) children born to
mothers with and without GDM, children who were LGA
and born to mothers with GDM had the greatest risk of
developing metabolic syndrome [56]. Another study showed
that children born to mothers with GDM had increased odds
of being overweight in adolescence (controlling for maternal
SES,breastfeedinghistory,smoking,andchilddietandphys-
ical activity) [57]. However, this relationship was attenuated
after taking into account birth weight and maternal weight.
This study suggests that the metabolic changes that occur to
the in utero environment when the mother develops gesta-
tional diabetes aﬀects the child’s birth weight, which then
inﬂuences the child’s risk for developing obesity. However,
thefactthatmaternalweightattenuatedtherelationshipcalls
into question whether there are other genetic factors that are
passed on from mother to child that predispose both mother
and child to increased weight and/or diabetes-like char-
acteristics. These common genetic factors may ultimately
make them more at risk when exposed to toxic nutritional
environments postnatally.
Outsideofmaternalweightgainandmetabolicdisorders,
maternal smoking is an environmental factor that seems to
aﬀectchildweightstatus.Anobservational studyin Australia
using a cohort of 3253 children demonstrated that mothers
who smoked during pregnancy compared to nonsmokers
had higher odds of having overweight (OR = 1.30, 95% CI
1.05–1.60) or obese (OR = 1.40, 95% CI 1.01–1.94) children
at 14 years of age, controlling for maternal education,
income, breast feeding history, and child’s diet and physical
activity [58]. Their study suggests that smoking speciﬁcally
during the gestational period may have an impact on the
development of the child. Infants born of smoking mothers
appear to be smaller for gestational age or have lower birth
weight than those of nonsmoking mothers [59–61], yet have
a greater percentage of body fat and lower percentage of lean
mass [62]. A recent study, however, found that providing
folicacidsupplementstomotherswhosmokedreducedtheir
risk of having children with low birth weight [63]. Folic acid
is a major methyl donor known to epigenetically alter the
expression of genes. Thus, while smoking appears to impact
one’s risk for obesity, other nutritional factors like folic
acid may be able to counteract these eﬀects, demonstrating
the plasticity of the human genome during the prenatal
period.International Journal of Pediatrics 5
Finally, greater weight gain velocity during the ﬁrst year
of life is associated with up to a ﬁvefold increased risk of
obesity later in life [64–66]. While the relationship between
absolute birth weight and later risk for obesity is less clear
[67], the relationship between accelerated catch-up growth
and obesity risk is particularly salient among children who
are born small for gestational age [68]. In industrialized
nations, children who gain weight quickly during the ﬁrst
year of life seem to be particularly prone to later obesity,
insulin resistance, and cardiovascular disease [69–71]. These
ﬁndings have caused many providers to question the optimal
rate of catch-up growth. However, the same genetic factors
that make one child more likely to have excess catch-up
growthmayalsoaﬀecttheirriskforobesity.Thusearlycatch-
up growth may simply be a manifestation of one’s genetic
potentialtostoreexcessenergyasfatandbecomeoverweight.
6. Discussion
While we are unable to alter which genes we are born with,
ﬁndingsfromanimalandhumanstudiessuggestthatwemay
be able to aﬀect the expression of these genes and therefore
our risk for future disease states. It is still unclear whether
or not interventions can help curb the genetic inﬂuence of
obesity. However, there are several potential lines for future
investigation.
One area worth exploring is how to reduce excess gesta-
tional weight gain. It appears that excess weight gain in preg-
nancy has deleterious eﬀects on child weight and increases
risk for delivering heavy infants [72–74]. However, it is still
unclear how best to limit excess gestational weight gain
and what the impact of such interventions is on oﬀspring
growth and development. In 2009, the IOM updated their
recommendations to limit weight gain during pregnancy to
15–25lbs. for overweight women and 11–20lbs. for obese
women [75]. However, reports suggest that 50% to 60% of
overweight women gain more than recommended [74, 76].
At this time, few studies have evaluated interventions
during pregnancy to promote weight gain within these re-
commendations [77]. Outside of bariatric surgery, weight
control studies for pregnant women suggest that lifestyle
changes that include behavioral counseling, monitoring
weight gain, limiting caloric intake, and increasing physical
activity may curb excessive gestational weight gain [78]. In
one study of women with gestational diabetes, dietary and
physical activity modiﬁcations were related to lower infant
birth weight and lower risk for-large-for-gestational-age
newborns, despite minimal changes in GDM risk [79]. Un-
fortunately, most research to date has not been randomized
and contains sample sizes too small to examine the impact of
interventions on oﬀspring weight trajectories. Nevertheless,
available research suggests that limiting gestational weight
gain has not been associated with increased adverse out-
comesfortheinfantintheneonatalperiod[72–74].Ongoing
research by the LIFE-MOMS NIH consortium of studies
will help inform whether reducing gestational weight gain in
obese women can reduce the risk of oﬀspring obesity. More
work is needed in order to understand how best to limit
excess gestational weight gain or GDM in women, increase
the eﬀectiveness of lifestyle interventions, and understand
how these interventions inﬂuence oﬀspring obesity risk.
Maternal nutritional exposure and dietary composition
during pregnancy is another area that requires attention.
As seen in animal studies, exposure to certain methylating
agents and the quality/quantity of maternal dietary intake
during pregnancy can inﬂuence the expression of certain
hormones and neuropeptides in the infant and the subse-
quent development of obesity. Similar methyl donor studies
in humans would be diﬃcult to conduct because of ethical
considerations and the diﬃculty in controlling for the myr-
iad of other inﬂuences that aﬀect a child’s risk for obesity.
However, randomized trials could test the inﬂuence of
maternal dietary prescriptions during pregnancy (e.g., low
glycemic diet, low-fat diet, low-energy-dense diet) on mater-
nal/fetal outcomes. Such research should include repeat
assessments of maternal diet during pregnancy and infant
intakepostpartum.Atthesametime,additionalanimalstud-
ieswillneedtobeconductedtomorepreciselydeterminethe
eﬀect of speciﬁc nutritional elements and diets on hormone
levels, gene expression, and obesity risk in the oﬀspring, as
well as determine the timing of these exposures during preg-
nancy.
With regards to postnatal inﬂuences, breastfeeding has
been associated with a decreased risk of obesity in children
[80]. However, it is unclear whether children born to over-
weightmothersormotherswithexcessiveweightgainduring
pregnancy can reduce their child’s risk of obesity through
breastfeeding. While some observational studies suggest that
breastfeeding in this situation may be protective for future
child overweight and the development of type 2 diabetes
[81] ,o t h e rs t u d i e sd on o t[ 82]. Unfortunately, a randomized
control trial around breastfeeding similar to the animal stud-
ies that involve cross-fostering would be diﬃcult to propose
in humans. Therefore, prospective studies that follow the
growthtrajectoryofchildrenovertimeandtakeintoaccount
the overweight mother’s prepregnancy weight, gestational
weight gain, metabolic parameters, detailed feeding history
during the ﬁrst year of life as well as the child’s subsequent
diet and physical activity history may help to better clarify
the impact of breast feeding on human risk for obesity
among those born to mothers who are overweight, had
excess gestational weight gain or diabetes during pregnancy.
Given the animal studies on HC milk, a comparison between
formula and breast milk consumption in infants born to
overweight mothers would also be of interest.
While we know that epigenetic changes can occur in the
postnatal period, it is uncertain how long after birth changes
in hormone and neuropeptide expression can be altered.
To date, few studies have been conducted that address the
impact of feeding behaviors and nutritional quality (outside
of breast feeding) in infancy and early childhood. Currently,
several studies are being conducted (in the United States
and Australia) that are exploring the eﬃcacy of maternal
education around nutrition and feeding behaviors during
infancy on later child dietary habits, physical activity, seden-
tary activity, and weight gain [83–85]. While the results of
thesestudiesarepending,anotherstudyconductedinTurku,6 International Journal of Pediatrics
Finland (the STRIP Baby project) intervened on fat intake
among infants starting at 7 months of age. They showed that
children in the intervention group had decreased cholesterol
and saturated fat consumption [86], as well as lower serum
cholesterol levels, LDL levels, enhanced endothelial function,
and lower blood pressure as they entered adolescence [87–
89]. Unfortunately, their study did not focus on overall
calorie restriction and its impact on obesity status was only
signiﬁcant among girls [90]. We also do not know whether
these dietary changes had an eﬀect on gene expression.
Nevertheless,morestudiesliketheseareneededtodetermine
the quality and quantity of nutritional intake in the postnatal
period as well as the intensity of the interventions that are
needed to curb the risk for obesity. Similar studies in SGA
and LGA infants would be particularly useful since these
children manifest a greater risk for obesity in later life and
their optimal rate of growth in the neonatal period is still
in question. However, animal studies will still be needed
in order to examine the metabolic and molecular impact
of these interventions and determine how long after birth
epigenetic changes can occur.
The ultimate goal will be to develop systems-wide
environmentalorpolicychanges(liketherecentIOMrecom-
mendations for gestational weight gain) that take advantage
of the mounting epigenetic evidence around obesity risk. At
this time, most of the studies in this area are laboratory-
based animal studies where exposures can be controlled and
testing for epigenetic evidence of change is more feasible.
Translatingtheresultsofthesestudiestohumansmayinvolve
designing community-based intervention studies comparing
the eﬀects of diﬀerent approaches (e.g., nutritional inter-
ventions in healthcare settings) on oﬀspring obesity risk.
Other nonrandomized studies could involve comparisons
among clearly deﬁned closed cohorts where, for example,
access to certain nutritional additives is currently limited,
religious or cultural practices prescribe limits on the intake
of certain foods (like animal fat or protein) or during natural
events that result in nutritional deprivation. Because of the
inability to control for all inﬂuences and examine biological
or molecular mechanisms on a populationwide level, we
will frequently have to rely on animal studies to clarify the
possible mechanisms of action. As greater evidence develops,
policy wide changes regarding nutritional additives to food
products (like Vitamin D in milk and iron in cereals), dietary
recommendations during pregnancy, the composition of
formula, the optimal timing of the introduction of solids,
and the optimal rate of growth may help to decrease the risk
for obesity in certain populations.
Genes can greatly aﬀect one’s risk of obesity. However,
there are several epigenetic inﬂuences that can alter the
expression of our genes and ultimately our risk of becoming
obese. These factors, in conjunction with the obesogenic
environment,resultinacomplexwebofinﬂuencethatcanbe
diﬃcult to change. At this point, we are beginning to under-
stand the importance of maternal gestational weight and
nutritional factors on oﬀspring obesity risk. We also know
that epigenetic changes can occur prenatally, postnatally
and sometimes can be carried over to the next generation
without any additional manipulations. The overarching
inﬂuence of these epigenetic changes help to explain the
growing prevalence of obesity around the world in a time
when genomic changes have not occurred. However, more
work needs to be done to determine if there are critical
periods for these eﬀects, the impact of other nutritional
elements and dietary compositions during pregnancy and
the postnatal period, and the impact of other environmental
toxins on epigenetic expression. Given the limitations of
human studies, laboratory-based animal studies will provide
insightregardingtheunderlyingmechanismsofaction.Once
mechanisms and timing of action are determined, additional
studies will be needed to develop novel interventions that
eﬀect behavior change and, ultimately, study the impact of
policy changes on obesity rates. Because of the developments
in the ﬁeld of epigenetics, we now have new insight into the
plausible mechanisms that explain the rise in obesity world-
wide. With this information, we will be able to develop novel
interventions for potential critical periods (i.e., pregnancy
and early childhood) to reduce the lifetime risk of obesity.
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